Logo image of CLSK

CLEANSPARK INC (CLSK) Stock Fundamental Analysis

NASDAQ:CLSK - Nasdaq - US18452B2097 - Common Stock - Currency: USD

9.25  -0.81 (-8.05%)

After market: 9.38 +0.13 (+1.41%)

Fundamental Rating

5

Overall CLSK gets a fundamental rating of 5 out of 10. We evaluated CLSK against 284 industry peers in the Software industry. CLSK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CLSK has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination!


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CLSK had positive earnings in the past year.
In the past year CLSK has reported a negative cash flow from operations.
In the past 5 years CLSK always reported negative net income.
CLSK had negative operating cash flow in 4 of the past 5 years.
CLSK Yearly Net Income VS EBIT VS OCF VS FCFCLSK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100M -200M -300M

1.2 Ratios

The Return On Assets of CLSK (2.42%) is better than 67.39% of its industry peers.
CLSK has a better Return On Equity (3.32%) than 67.39% of its industry peers.
Industry RankSector Rank
ROA 2.42%
ROE 3.32%
ROIC N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
CLSK Yearly ROA, ROE, ROICCLSK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

CLSK has a better Profit Margin (14.36%) than 81.16% of its industry peers.
CLSK has a Gross Margin of 55.74%. This is in the lower half of the industry: CLSK underperforms 65.94% of its industry peers.
In the last couple of years the Gross Margin of CLSK has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 14.36%
GM 55.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
CLSK Yearly Profit, Operating, Gross MarginsCLSK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

4

2. Health

2.1 Basic Checks

CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CLSK has been increased compared to 1 year ago.
Compared to 5 years ago, CLSK has more shares outstanding
The debt/assets ratio for CLSK is higher compared to a year ago.
CLSK Yearly Shares OutstandingCLSK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
CLSK Yearly Total Debt VS Total AssetsCLSK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 2.70 indicates that CLSK is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of CLSK (2.70) is comparable to the rest of the industry.
CLSK has a Debt/Equity ratio of 0.32. This is a healthy value indicating a solid balance between debt and equity.
CLSK's Debt to Equity ratio of 0.32 is on the low side compared to the rest of the industry. CLSK is outperformed by 61.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Altman-Z 2.7
ROIC/WACCN/A
WACC13.95%
CLSK Yearly LT Debt VS Equity VS FCFCLSK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 12.67 indicates that CLSK has no problem at all paying its short term obligations.
With an excellent Current ratio value of 12.67, CLSK belongs to the best of the industry, outperforming 97.10% of the companies in the same industry.
CLSK has a Quick Ratio of 12.67. This indicates that CLSK is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 12.67, CLSK belongs to the top of the industry, outperforming 97.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 12.67
Quick Ratio 12.67
CLSK Yearly Current Assets VS Current LiabilitesCLSK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 186.67% over the past year.
CLSK shows a strong growth in Revenue. In the last year, the Revenue has grown by 118.07%.
The Revenue has been growing by 142.70% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)186.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1775%
Revenue 1Y (TTM)118.07%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%119.97%

3.2 Future

The Earnings Per Share is expected to grow by 126.46% on average over the next years. This is a very strong growth
Based on estimates for the next years, CLSK will show a very strong growth in Revenue. The Revenue will grow by 34.35% on average per year.
EPS Next Y657.42%
EPS Next 2Y370.05%
EPS Next 3Y126.46%
EPS Next 5YN/A
Revenue Next Year127.44%
Revenue Next 2Y73.86%
Revenue Next 3Y34.35%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CLSK Yearly Revenue VS EstimatesCLSK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CLSK Yearly EPS VS EstimatesCLSK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 -4

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.86, the valuation of CLSK can be described as very reasonable.
Based on the Price/Earnings ratio, CLSK is valued cheaper than 90.22% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.63, CLSK is valued rather cheaply.
The Price/Forward Earnings ratio is 5.98, which indicates a rather cheap valuation of CLSK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CLSK indicates a rather cheap valuation: CLSK is cheaper than 98.55% of the companies listed in the same industry.
CLSK is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.68, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 11.86
Fwd PE 5.98
CLSK Price Earnings VS Forward Price EarningsCLSK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CLSK is valued cheaply inside the industry as 80.43% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 24.66
CLSK Per share dataCLSK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

CLSK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CLSK's earnings are expected to grow with 126.46% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y370.05%
EPS Next 3Y126.46%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CLSK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEANSPARK INC

NASDAQ:CLSK (2/21/2025, 8:10:04 PM)

After market: 9.38 +0.13 (+1.41%)

9.25

-0.81 (-8.05%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-06 2025-02-06/amc
Earnings (Next)05-07 2025-05-07/amc
Inst Owners54.13%
Inst Owner Change33.71%
Ins Owners2.32%
Ins Owner Change74.59%
Market Cap2.60B
Analysts82.67
Price Target24.33 (163.03%)
Short Float %27.13%
Short Ratio2.57
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.02
Dividend Growth(5Y)N/A
DP5.1%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)25.54%
Min EPS beat(2)-46.57%
Max EPS beat(2)97.65%
EPS beat(4)2
Avg EPS beat(4)217.27%
Min EPS beat(4)-345.63%
Max EPS beat(4)1163.62%
EPS beat(8)5
Avg EPS beat(8)90.33%
EPS beat(12)6
Avg EPS beat(12)29.16%
EPS beat(16)7
Avg EPS beat(16)36.1%
Revenue beat(2)1
Avg Revenue beat(2)1.71%
Min Revenue beat(2)-1.26%
Max Revenue beat(2)4.69%
Revenue beat(4)2
Avg Revenue beat(4)0.58%
Min Revenue beat(4)-7.95%
Max Revenue beat(4)6.85%
Revenue beat(8)3
Avg Revenue beat(8)-0.21%
Revenue beat(12)4
Avg Revenue beat(12)-3.15%
Revenue beat(16)4
Avg Revenue beat(16)-8.24%
PT rev (1m)-2.99%
PT rev (3m)0.68%
EPS NQ rev (1m)-0.61%
EPS NQ rev (3m)399.75%
EPS NY rev (1m)-60.54%
EPS NY rev (3m)-42.44%
Revenue NQ rev (1m)33.47%
Revenue NQ rev (3m)34.23%
Revenue NY rev (1m)0%
Revenue NY rev (3m)15.79%
Valuation
Industry RankSector Rank
PE 11.86
Fwd PE 5.98
P/S 5.56
P/FCF N/A
P/OCF N/A
P/B 1.28
P/tB 1.38
EV/EBITDA 24.66
EPS(TTM)0.78
EY8.43%
EPS(NY)1.55
Fwd EY16.72%
FCF(TTM)-1.83
FCFYN/A
OCF(TTM)-1.11
OCFYN/A
SpS1.66
BVpS7.2
TBVpS6.7
PEG (NY)0.02
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.42%
ROE 3.32%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 14.36%
GM 55.74%
FCFM N/A
ROA(3y)-12.83%
ROA(5y)-29.98%
ROE(3y)-14.38%
ROE(5y)-38.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.33%
GM growth 5Y29.35%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 0.32
Debt/FCF N/A
Debt/EBITDA 4.95
Cap/Depr 105.61%
Cap/Sales 43.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 12.67
Quick Ratio 12.67
Altman-Z 2.7
F-Score4
WACC13.95%
ROIC/WACCN/A
Cap/Depr(3y)65.93%
Cap/Depr(5y)337.91%
Cap/Sales(3y)31.8%
Cap/Sales(5y)89.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)186.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1775%
EPS Next Y657.42%
EPS Next 2Y370.05%
EPS Next 3Y126.46%
EPS Next 5YN/A
Revenue 1Y (TTM)118.07%
Revenue growth 3Y112.85%
Revenue growth 5Y142.7%
Sales Q2Q%119.97%
Revenue Next Year127.44%
Revenue Next 2Y73.86%
Revenue Next 3Y34.35%
Revenue Next 5YN/A
EBIT growth 1Y38.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year665.4%
EBIT Next 3Y104.98%
EBIT Next 5YN/A
FCF growth 1Y-950.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-592.57%
OCF growth 3YN/A
OCF growth 5YN/A